Eli Lilly & Company in the IMPRESS study
Eli Lilly & Company is now part of the national Norwegian IMPRESS study.
This author has yet to write their bio.Meanwhile lets just say that we are proud CONNECT contributed a whooping 54 entries.
Eli Lilly & Company is now part of the national Norwegian IMPRESS study.
Statsbudsjettet for 2022 inneholder lite for kreftpasienter og innovasjon innen kreftbehandling.
Did you know that Oslo Cancer Cluster is a changemaker?
The Research Council of Norway recently awarded grants to several innovation projects in the industrial sector. One of the lucky companies was the newcomer NordicRWE.
Oslo Cancer Cluster is an oncology research and industry cluster dedicated to improving the lives of cancer patients by accelerating the development of new cancer diagnostics and medicines.
We are a national non-profit member organization with about 90 members. Our members are Norwegian and international companies, research and financial institutions, university hospitals and organizations – all working in the cancer field.